Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy-Reference-Cited by-同舟云学术

Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy

Published:2012-07-24 Issue:3 Volume:27 Page:e282-e288
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:

Author:

Álvarez M.A.,Ruano J.,Gómez F.J.,Casas E.,Baamonde C.,Salvatierra A.,Moreno J.C.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2012.04630.x/fullpdf

Reference16 articles.

1. Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial;Connor;J Clin Psychiatry,2006

2. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life;Solish;Dermatol Surg,2005

3. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee;Solish;Dermatol Surg,2007

4. Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis;Wolosker;J Vasc Surg,2010

5. Compensatory sweating after thoracoscopic sympathectomy: characteristics, prevalence and influence on patient satisfaction;Araújo;J Bras Pneumol,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis;American Journal of Clinical Dermatology;2019-05-20

2. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials;Journal of the American Academy of Dermatology;2019-01

3. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials;Pediatric Dermatology;2018-11-19

4. New trends in botulinum toxin use in dermatology;Dermatology Practical & Conceptual;2018-10-31

5. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials;American Journal of Clinical Dermatology;2018-10-30